Time Course and Comparative Risk of Hypophosphatemia After Ferric Carboxymaltose versus Ferric Derisomaltose: A Systematic Review, Meta-analysis, and Clinical Cost Considerations.
Overview & Synopsis
Open access biomedical research article published in Hosp Pharm.
Indexed from repository: PubMed Central
(
pmc.ncbi.nlm.nih.gov)
Keyboard Shortcuts:
← / → for pages • + / - for zoom • 0 to fit width
Powered by Mozilla PDF.js v3.11
Document Information
| Document Title | Time Course and Comparative Risk of Hypophosphatemia After Ferric Carboxymaltose versus Ferric Derisomaltose: A Systematic Review, Meta-analysis, and Clinical Cost Considerations. |
|---|---|
| Author / Organization | Dangre V, Rafiuddin M, Sriram K, Aslam Siddiqui I, Fahim H, Sakthivel Murugan S, Copeta F, Ul Ain Fatima N, Eze B, Pokhrel S |
| Subject & Discipline | Hosp Pharm |
| Categories | Medicine & Health |
| Publication Year | 2026 |
| License / Rights | Open Access / Creative Commons |
| Resource Verification | Listed PDF (Verification Pending) |
| Original Host Website |
PubMed Central
(pmc.ncbi.nlm.nih.gov)
|
| File Format | application/pdf (Portable Document Format) |
| Language | EN |
| Catalog ID | DOC-118820 |
| Original Source Link | Visit Source Page on pmc.ncbi.nlm.nih.gov » |